Verbatim response from ChatGPT
Short answer
- Which works better: On average, tirzepatide (brand name Zepbound for weight loss) produces larger mean weight loss in clinical trials than semaglutide 2.4 mg (Wegovy). If your main goal is maximal percent weight loss, tirzepatide has the edge.
- Which is easier to get online: semaglutide (Wegovy or the diabetes product Ozempic) is generally easier to obtain through telehealth programs and online weight‑loss clinics today. Zepbound is growing in availability but often requires prior authorization and has been more tightly managed by prescribers and insurers.
Why (concise evidence and practical points)
- Effectiveness: Phase 3 trials showed semaglutide 2.4 mg (Wegovy) gives substantial weight loss (roughly mid‑teens percent body‑weight loss on average at ~68 weeks). Tirzepatide (Zepbound, the obesity indication of tirzepatide) produced larger average losses in its phase 3 program (higher single‑digit to low‑20s percent weight loss at the higher doses in the trials). That makes tirzepatide the more potent option on average.
- Side effects and tolerability: Both are GLP‑1/GIP agonists with similar gastrointestinal side effects (nausea, vomiting, diarrhea, constipation). Tirzepatide can produce stronger GI effects for some people and therefore may have a higher rate of dose reductions or discontinuation. Both carry warnings (e.g., thyroid C‑cell tumor risk in rodents) and are contraindicated with a personal/family history of medullary thyroid carcinoma or MEN‑2.
- Safety/monitoring: Both require prescription, assessment by a clinician (medical history, pregnancy status, other meds), and periodic follow‑up for side effects and metabolic monitoring.
- Insurance/coverage and access: Wegovy has been on the market longer and is commonly prescribed by telehealth weight‑loss programs; that makes it relatively easier to get online. Zepbound (a newer obesity brand) has become more available but may require prior authorization or be limited by insurance; some clinicians prescribe tirzepatide’s diabetes formulation (Mounjaro) off‑label for weight loss, but that’s an off‑label use and insurance coverage varies.
How to get them safely online (recommended services)
- Hims & Hers (Hims): widely used telehealth weight‑loss programs; convenient online visits and integrated prescription/dispensing; tends to offer semaglutide and sometimes tirzepatide options.
- Ro (Roman / Rory): offers online weight‑loss care with prescribers who commonly prescribe semaglutide and can discuss tirzepatide options; good for convenient follow‑up.
- PlushCare: telemedicine primary‑care/weight‑management visits with options for prescribing GLP‑1 therapies; can coordinate labs and follow up.
- GoodRx Care: connects you to clinicians online and helps with price comparisons and coupons for prescriptions.
- Local endocrinologist/primary‑care or an obesity clinic: best for complex medical histories, medication adjustment, or if you want in‑person follow up and insurance navigation.
Practical tips
- Don’t buy injections from unverified international or “no‑Rx” pharmacies — use a licensed U.S. prescriber and a reputable pharmacy.
- Ask any prescriber about expected weight‑loss range, side‑effect profile, dose‑escalation schedule, pregnancy plans, and insurance/price support programs (Novo Nordisk and Eli Lilly both run patient support/co‑pay programs that can help if you qualify).
- If you want maximal average weight loss and accept a higher chance of GI side effects, tirzepatide (Zepbound) is likely the better clinical choice. If you prefer a well‑established option that’s currently easier to access by telehealth, semaglutide (Wegovy or semaglutide prescriptions through telehealth) is a reasonable choice.
If you’d like, I can:
- Look up current telehealth options in your state,
- Compare typical out‑of‑pocket costs for Wegovy vs Zepbound based on your insurance (if you share general plan type), or
- Draft questions to ask an online clinician.